Type to search

Roche Receives FDA Approval for First Companion Diagnostic to Identify dMMR Solid Tumour Patients Eligible for Anti-PD-1 Immunotherapy | Pharmtech Focus
Tezepelumab Regulatory Submission Accepted and Granted FDA Priority Review in the US for the Treatment of Patients with Asthma | Pharmtech Focus
FDA Approval of Aducanumab | Pharmtech Focus